Clinical trial
Screening for Atrial Fibrillation With Prolonged Continuous Single-lead ECG Devices in High-risk Patients
NCT04519190 is registered in ClinicalTrials.gov with Huashan Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Screening for Atrial Fibrillation With Prolonged Continuous Single-lead ECG Devices in High-risk Patients
- Lead sponsor
- Huashan Hospital
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- August 25, 2020
- Completion date
- August 31, 2023
- Enrollment
- 300 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.